4D Molecular Therapeutics (FDMT)
(Delayed Data from NSDQ)
$31.86 USD
-4.01 (-11.18%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $31.86 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/08/2024
Time: -- |
3/2024 | $-0.71 | 0.00% |
Earnings Summary
For their last quarter, 4D Molecular Therapeutics (FDMT) reported earnings of -$0.77 per share, missing the Zacks Consensus Estimate of -$0.68 per share. This reflects a negative earnings surprise of 13.24%. Look out for FDMT's next earnings release expected on May 08, 2024. For the next earning release, we expect the company to report earnings of -$0.71 per share, reflecting a year-over-year increase of 19.32%.
Earnings History
Price & Consensus
Zacks News for FDMT
Strength Seen in Lyra Therapeutics, Inc. (LYRA): Can Its 6.9% Jump Turn into More Strength?
FDMT: What are Zacks experts saying now?
Zacks Private Portfolio Services